Diabetes drugs linked to fewer deaths in young adults
Among young adults with type 2 diabetes, semaglutide users had a one-year relative risk of death of 0.416 compared with metformin users.Among young adults with type 2 diabetes, semaglutide users had a one-year relative risk of death of 0.416 compared with metformin users.